Informa Markets, in partnership with IMPACT Exhibition Management Co., Ltd., have confirmed that Medlab Asia and Asia Health will return to Thailand following the success of the 2022 edition of the show, after shining a spotlight on the growth of the healthcare and laboratory industries in South East Asia and securing business deals worth over US$35 million last year.
According to the ASEAN Medical Diagnostics Market: Insights & Forecasts with Potential Impact of Covid-19 report, the Association of South East Asian Nations (ASEAN) medical diagnostics market is anticipated to reach over US$14 billion by 2026, denoting a compound annual growth rate (CAGR) of 12.60% between 2022 and 2026.
The research revealed a range of factors contributing to this growth, including an ageing population, increased stress levels, growing healthcare expenditure, expanding urbanisation and a surge in western-type diseases. This, in turn, is creating various new trends within the health and laboratory sectors, such as an upsurge in medical tourism, the emergence of point-of-care testing (POC) and rapid testing, growing awareness of personalised medicine and new specialised tests and escalating shift towards preventive healthcare.
Tom Coleman, Exhibition Director, Informa Markets said: “With the unprecedented growth of the healthcare and laboratory industries in South East Asia, the timely return of Medlab Asia and Asia Health, will showcase the latest innovations and technology driving the industry forward in the region, as well as providing the ideal platform for meeting colleagues and discussing the latest trends impacting their respective industries.
“Last year was the first time the events were held live and in-person, so following its success, it was of paramount importance we returned to continue to provide a stage to connect buyers and suppliers from the laboratory and healthcare industries in the region and globally.”
This year the co-located events are expected to welcome more than 5,000 visitors from over 50 countries during the 7th edition of the shows, with more than 500+ exhibitors expected to showcase the latest cutting-edge technology taking the healthcare world by storm, with artificial intelligence (AI), augmented reality (AR), and virtual reality (VR) to take centre stage.
Elsewhere on the show floor, there will be six dedicated product sectors, including medical equipment and devices, imaging and diagnostics, disposables and consumer goods, healthcare and general services, emergency medicine, and wellness and prevention.
Loy Joon How, General Manager of IMPACT Exhibition Management, said: “Medlab Asia & Asia Health 2023 will be welcoming world-class suppliers and industry leaders as well as top-of-the-line buyers in the healthcare and laboratory sector to explore the APAC market. The show is set to bring together healthcare and laboratory professionals from ASEAN countries to network, learn and do business.”
A total of eight clinical conferences will take place as part of Asia Health, including Total Radiology, Sterilisation & Decontamination, Doing Business in Thailand, and for the first time, Digital Health, Nursing, the Future Health Panel, Emergency Medicine, and Patient Safety & Infection Control. Medlab Asia will host six conferences, including Laboratory Management, Clinical Chemistry, Clinical Microbiology, Molecular Diagnostics, and Haematology and new for this year is Immunology.
Both events are expected to be supported by a host of government entities and influencers in their respective sectors, with industry leaders such as Randox Laboratories Ltd, Sansure Biotech, Autobio, Quotient and Snibe already confirmed.